Terrie Curran - Nov 1, 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
President and Chief Executive, Director
Signature
/s/ Larry Miller, Attorney-in-Fact for Terrie Curran
Stock symbol
PHAT
Transactions as of
Nov 1, 2023
Transactions value $
$0
Form type
4
Date filed
11/3/2023, 04:53 PM
Previous filing
Jul 17, 2023
Next filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +37.5K +9.62% $0.00 427K Nov 1, 2023 Direct F1
holding PHAT Common Stock 3.58K Nov 1, 2023 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.